Company Profile
PharmaVision was created by Dr Cheryl Lee Barton in 2002 to provide independent, tailor made pharmaceutical thematic research to investment houses, competitive intelligence specialists and pharmaceutical companies. The research reports combine independent scientific analysis with market models to forecast the potential growth of key developmental products and technologies.
Pharmavision was formed in order to write and publish independent and impartial analysis of the pharmaceutical industry with a focus on drug delivery, it’s players, their products and the issues surrounding this specialist sector. Using PharmaVision's market modeling and analysis insight, we aim to deliver market analysis papers of quality and value to its readers.
Latest Papers
 The Future of Nutrigenomics:New opportunities in personalized nutrition and food-pharma collaboration Nutrigenomics explores how nutrients or bioactive dietary compounds can influence gene expression and an individuals risk to certain diseases. Nutrigenetics is the study of how variations in an individual’s genetic makeup can increase or decrease the... Price: £3,213.00 Author: Dr Cheryl L Barton / Date Published: 18 January 2010 |
|
Innovations In Epigenetics Advances in Technologies, Diagnostics & Therapeutics The study of epigenetics - changes in gene expression that occur without a change in a cell’s DNA code – is becoming increasingly important as scientists explore how internal and external factors trigger cellular dysfunction and influence disease pro... Price: £2,570.00 Author: Dr Cheryl l Barton / Date Published: 27 November 2009 |
|
Key Players and Innovative Start-ups in Nutraceuticals Emerging strategies in ingredients, pharma, food and drinks Nutraceuticals are bioactive compounds with properties beneficial to health that are often concentrated extracts from fruits, herbs, seeds, specific lipids and vegetables. Nutraceuticals are often used to fortify food products, creating functional fo... Price: £3,214.00 Author: Dr Cheryl L Barton / Date Published: 02 November 2009 |
